Please login to the form below
Consideration
This page shows the latest Consideration news and features for those working in and with pharma, biotech and healthcare.
Biogen and Eisai’s Alzheimer’s drug to be covered by US Veterans Health Administration
The VHA's careful consideration and timely action to make Leqembi available approximately two months after the US Food and Drug Administration (FDA) approved Leqembi under the accelerated approval pathway shows
Latest news
-
German Chapter of the Healthcare Communications Association launched
HCA CEO Mike Dixon added: “The central activity the HCA undertakes already reaches communicators in many countries, but there will always be specific considerations to champion at a national level and
-
WHO announces recommended 2023-24 flu vaccines for northern hemisphere
The objectives are to:. Analyse the antigenic and genetic characteristics of the seasonal influenza viruses that are circulating, taking into consideration the available epidemiological and clinical information from individual countries and
-
Gilead reports positive real-world evidence for COVID-19 treatment Veklury
These longitudinal analyses demonstrate the value of [Veklury] in reducing mortality in all patients with COVID-19, and its positive impact on reducing readmission rates, which is an important consideration for
-
FDA external report recommends actions to address US opioid crisis
public health considerations.
-
UN report highlights role of pharma pollution in growing antimicrobial resistance threat
This includes improving water management and sanitation, integrating environmental considerations into AMR national action plans and developing international standards for what constitutes a good microbiological indicator of AMR from environmental
More from news
Approximately 0 fully matching, plus 454 partially matching documents found.
Latest Intelligence
-
The increasing value of rare disease trials
Trial design and delivery in the rare disease arena bring considerations and potential pitfalls for researchers, patients, pharma and regulators.
-
Rare diseases: not so rare after all
In the case of LSDs, consideration would need to be given to what an improvement to replacing the missing enzyme would look like.
-
The challenges of identifying rare diseases
It should be taken into consideration that this estimation does not take into account that some rare conditions can be treated with interventions other than drugs, such as surgery or diet,
-
Digital technology: a significant change in healthcare innovation
Challenges and considerations for the future use of digital health technology.
-
Design considerations and best practices in clinical research
However, because ECA studies join data from two different sources (ie, the comparator arm and the SAT), there are several considerations prior to initiating a study to ensure scientifically valid findings.
More from intelligence
Approximately 0 fully matching, plus 167 partially matching documents found.
Latest appointments
-
NDA bolsters its senior team
regulatory and market access considerations to meet their goals.”.
-
EMA’s Pharmacovigilance Risk Assessment Committee gains new members
Its objective is to assess and monitor safety issues for human medicines, giving recommendations for consideration by the Committee for Medicinal Products for Human Use (CHMP). ... The EMA said: “Their role is to bring the views, concerns and
-
Larry Bell joins Dutch biopharma Prosensa
As the orphan drugs space grows in size and scope, there are many regulatory considerations that need to be addressed in order for new drugs to reach the patients that need
More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest from PMHub
-
Could femtech be the answer to the gender health gap?
If this is to be the case, a key consideration will be that while the primary audience for femtech right now is of an age more likely to engage with technology ... Lack of consideration of sex and gender in COVID-19 clinical studies.
-
End-to-end patient strategy: Making a treatment for patients, with patients
key consideration for regulating bodies. ... 11. We know that patients may want different things from a treatment - rapid onset of treatment versus long durable remissions, oral outpatient treatment or hospital based care, consideration of the financial
-
Cuttsy+Cuttsy campaign takes health literacy to the North Pole
Nice’. Health literacy in practice. Improving health literacy is a big part of what we do, and the questions highlight just some of the considerations that we run through daily to ... Emotional awareness is also an important consideration in design;
-
Virtual Tools for Promoting Diversity in Pharma and Clinical Trials
Engaging advisors from different cultural/ethnic backgrounds, geographical regions, specialties, or levels of seniority allows consideration of new perspectives.
-
Medscape Medical Affairs are PMEA Finalists in Three Categories
Christina Hoffman, Global Head of Medscape Medical Affairs, commented, “We are thrilled our programme has been shortlisted for award consideration.
More from PMHub
Approximately 2 fully matching, plus 137 partially matching documents found.
Subscribe to our email news alerts
-
Senior Medical Writer
- Highly competitive salary
- Associate Director - Global Healthcare Consulting
- Highly competitive salary
-
Pharmacovigilance Manager
- Highly competitive salary
-
Pharmacovigilance Project Lead
- Highly competitive salary
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
-
Technical Sales Representative
- Highly competitive salary
- Strategy Director - Healthcare Advertising
- Highly competitive salary
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- MHRA to introduce new UK clinical trials framework
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- 2023 PM Society Awards – winners announced
- AstraZeneca/MSD’s Lynparza combination approved in UK for prostate cancer
- WHO report highlights impact of COVID-19 pandemic on non-communicable diseases
- Critical success factors and the increasing value of rare disease clinical trials
- Quantum Computing, Artificial Intelligence, & Machine Learning for Drug Discovery
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Locus Biosciences announces first patient treated in urinary tract infection trial
- GSK reports positive phase 3 results for five-in-one meningococcal vaccine candidate
- Kite reports positive three-year results for CAR T-cell therapy in rare blood cancer
- Results for Astellas’ non-hormonal menopause drug published in The Lancet
- Ketchum appoints Conor Nash as global chief financial officer and chief operating officer
PMHub
Kardex
Kardex is a global industry partner for intralogistics solutions and a leading supplier of automated storage solutions and material handling...
Latest intelligence
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
- Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
- Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...
